MX9703146A - Derivados de acido propenoico substituido con heterociclo como antagonistas de nmda. - Google Patents

Derivados de acido propenoico substituido con heterociclo como antagonistas de nmda.

Info

Publication number
MX9703146A
MX9703146A MX9703146A MX9703146A MX9703146A MX 9703146 A MX9703146 A MX 9703146A MX 9703146 A MX9703146 A MX 9703146A MX 9703146 A MX9703146 A MX 9703146A MX 9703146 A MX9703146 A MX 9703146A
Authority
MX
Mexico
Prior art keywords
acid derivatives
propenoic acid
nmda antagonists
heterocycle substituted
substituted propenoic
Prior art date
Application number
MX9703146A
Other languages
English (en)
Other versions
MXPA97003146A (es
Inventor
Boyd L Harrison
Philip L Nyce
Robert A Farr
Original Assignee
Hoechst Marion Roussel Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst Marion Roussel Inc filed Critical Hoechst Marion Roussel Inc
Publication of MXPA97003146A publication Critical patent/MXPA97003146A/es
Publication of MX9703146A publication Critical patent/MX9703146A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D407/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00
    • C07D407/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings
    • C07D407/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Hospice & Palliative Care (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Cardiology (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Indole Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Heterocyclic Compounds Containing Sulfur Atoms (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Pyrrole Compounds (AREA)

Abstract

Se describen derivados de ácido propenoico 3-(heteorcíclico) de la Formula (I), en donde G es un radical seleccionado del grupo a), b) o c). Estos derivados de ácido propenoico 3-(heterocíclico) son utiles como antagonistas de NMDA.
MX9703146A 1994-10-31 1995-09-21 Derivados de acido propenoico substituido con heterociclo como antagonistas de nmda. MX9703146A (es)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US08332016 US5563157B1 (en) 1994-10-31 1994-10-31 Heterocycle substituted propenoic acid derivatives and pharmaceutical compositions thereof
US332,016 1994-10-31
US332016 1994-10-31
PCT/US1995/012085 WO1996013501A1 (en) 1994-10-31 1995-09-21 Heterocycle substituted propenoic acid derivatives as nmda antagonists

Publications (2)

Publication Number Publication Date
MXPA97003146A MXPA97003146A (es) 1997-06-01
MX9703146A true MX9703146A (es) 1997-06-28

Family

ID=23296353

Family Applications (1)

Application Number Title Priority Date Filing Date
MX9703146A MX9703146A (es) 1994-10-31 1995-09-21 Derivados de acido propenoico substituido con heterociclo como antagonistas de nmda.

Country Status (21)

Country Link
US (3) US5563157B1 (es)
EP (1) EP0790994B1 (es)
JP (1) JP3934678B2 (es)
KR (1) KR100401138B1 (es)
CN (1) CN1068001C (es)
AT (1) ATE217307T1 (es)
AU (1) AU696423B2 (es)
CA (1) CA2202992C (es)
DE (1) DE69526668T2 (es)
DK (1) DK0790994T3 (es)
ES (1) ES2173198T3 (es)
FI (1) FI971831A0 (es)
HU (1) HU222372B1 (es)
IL (1) IL115791A (es)
MX (1) MX9703146A (es)
NO (1) NO313197B1 (es)
NZ (1) NZ293842A (es)
PT (1) PT790994E (es)
TW (1) TW336232B (es)
WO (1) WO1996013501A1 (es)
ZA (1) ZA959046B (es)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5922752A (en) * 1997-06-11 1999-07-13 Hoechst Marion Roussell, Inc. NMDA (n-methyl-d-aspartate) antagonists
GB9902455D0 (en) * 1999-02-05 1999-03-24 Zeneca Ltd Chemical compounds
EP1341761A1 (en) 2000-10-10 2003-09-10 Smithkline Beecham Corporation SUBSTITUTED INDOLES, PHARMACEUTICAL COMPOSITIONS CONTAINING SUCH INDOLES AND THEIR USE AS PPAR-$g(g) BINDING AGENTS
JP2005506292A (ja) * 2001-03-08 2005-03-03 エモリー　ユニバーシティ ｐＨに依存するＮＭＤＡレセプターアンタゴニスト
CN103058957A (zh) 2007-06-29 2013-04-24 埃莫里大学 用于神经保护的nmda受体拮抗剂

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR0178469B1 (ko) * 1990-07-16 1999-03-20 메이나드 알. 존슨 흥분성 아미노산 길항제
JP3094450B2 (ja) * 1990-10-15 2000-10-03 アストラゼネカ・アクチエボラーグ 神経保護特性を有するピペリジン誘導体
US5284862A (en) * 1991-03-18 1994-02-08 Warner-Lambert Company Derivatives of 2-carboxyindoles having pharmaceutical activity
GB9208492D0 (en) * 1992-04-16 1992-06-03 Glaxo Spa Heterocyclic compounds
ATE151750T1 (de) * 1993-05-27 1997-05-15 Merrell Pharma Inc 3-(indol-3-yl) propensäurderivate, die als nmda- antagonisten nützlich sind
US5519048A (en) * 1993-05-27 1996-05-21 Merrell Pharmaceuticals Inc. 3-(indol-3-yl)-propenoic acid derivatives and pharmaceutical compositions thereof

Also Published As

Publication number Publication date
CA2202992C (en) 2003-05-13
AU3638795A (en) 1996-05-23
HUT77174A (hu) 1998-03-02
PT790994E (pt) 2002-08-30
DE69526668T2 (de) 2003-01-02
TW336232B (en) 1998-07-11
WO1996013501A1 (en) 1996-05-09
AU696423B2 (en) 1998-09-10
JP3934678B2 (ja) 2007-06-20
IL115791A (en) 2000-09-28
US6180786B1 (en) 2001-01-30
JPH10508019A (ja) 1998-08-04
ZA959046B (en) 1996-05-17
US5981553A (en) 1999-11-09
FI971831A (fi) 1997-04-29
CN1068001C (zh) 2001-07-04
FI971831A0 (fi) 1997-04-29
EP0790994A1 (en) 1997-08-27
NO313197B1 (no) 2002-08-26
NO971991L (no) 1997-04-29
DE69526668D1 (de) 2002-06-13
US5563157B1 (en) 1999-02-02
NZ293842A (en) 1998-09-24
EP0790994B1 (en) 2002-05-08
DK0790994T3 (da) 2002-08-26
NO971991D0 (no) 1997-04-29
KR100401138B1 (ko) 2003-12-24
HU222372B1 (hu) 2003-06-28
IL115791A0 (en) 1996-01-19
US5563157A (en) 1996-10-08
ATE217307T1 (de) 2002-05-15
CA2202992A1 (en) 1996-05-09
ES2173198T3 (es) 2002-10-16
CN1161696A (zh) 1997-10-08

Similar Documents

Publication Publication Date Title
IL142649A0 (en) Azole derivatives
PT778277E (pt) Derivados heterociclicos substituidos como antagonistas do crf
AU2002211216A1 (en) Substituted aminopropoxyaryl derivatives useful as agonists for lxr
JPS5412381A (en) N-alkylpiperidine derivative
MY132671A (en) Substituted 6,6-hetero-bicyclic derivatives
MXPA02003977A (es) Inhibidores de adhesion de celula mediada por al°2.
AU1642795A (en) Substituted pyridylpyrazoles
DE69709938D1 (de) N-benzylpiperidin- und tetrahydropyridin-derivate
CA2379026A1 (en) Substituted thiene-3-yl-sulphonylamino(thio)carbonyl-triazolin(thi)ones
NO20016401L (no) Th2 differensieringsinhibitorer
TR200403436T2 (tr) Kristalin 1-metilkarbapenem türevleri.
IE851205L (en) Beta-carbolines
CA2037975A1 (en) 5-hydroxy-2,3-dihydrobenzofuran analogs as leukotriene biosynthesis inhibitors
MX9703146A (es) Derivados de acido propenoico substituido con heterociclo como antagonistas de nmda.
NO990914L (no) Amorfe benzotiofener, fremgangsmÕter for fremstilling og fremgangsmÕter for anvendelse
EP1026162A4 (en) ANTI-RHUMATISMAL AGENT
MX9900914A (es)
ES2195500T3 (es) Dereivados del 2-indanometanol y su utilizacion a titulo de ingredientes perfumantes.
YU3099A (sh) Novi derivati eritromicina, postupak za njihovo dobijanje i njihova primena
WO1992018474A3 (en) Novel 2-spirocyclopropyl cephalosporin sulfone derivatives and processes for the preparation thereof
MX9701764A (es) Derivados de imidoacidos.
JPS5432468A (en) Pyrrole derivatives
ES479033A1 (es) Un procedimiento para la preparacion de derivados de n-iminometil piperidina.
ES8505363A1 (es) Un procedimiento para preparar una 3-(2-furoil)-5-2,6-dimetil-4-(2-nitrofenil)-1,4-dihidropiridina
UA19166A1 (uk) Гербіцидhа композиція